DAVID NGUGI: Open Payments
NPI 1679114938 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 9 payments from 8 companies in 2025. Trend: 2023 $388 · 2024 $2,583 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Indivior Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: AUSTEDO XR, SUBLOCADE, JARDIANCE, ARISTADA, GVOKE HYPOPEN, Qelbree, CAPLYTA, VRAYLAR.
Industry payments across NC — which companies pay providers there.
